Has the time come to rethink the pathogenesis of asthma?

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 1, 2010, Pages 48-53

  Holgate, Stephen T ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Allergens; Asthma; Epithelium; Inflammation; Mesenchyme; Remodelling; Virus infection

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; IMMUNOGLOBULIN E ANTIBODY; MEPOLIZUMAB; MONTELUKAST; OMALIZUMAB; PEPTIDOLEUKOTRIENE;

AIR POLLUTION; ALLERGIC ASTHMA; ALLERGIC RHINITIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG MEGADOSE; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNOTHERAPY; INFLAMMATION; INNATE IMMUNITY; LUNG RESISTANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; REVIEW; T LYMPHOCYTE; UPREGULATION;

ALLERGENS; ASTHMA; BLOOD-AIR BARRIER; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; HUMANS; IMMUNITY, INNATE; INCIDENCE; RESPIRATORY MUCOSA; RISK FACTORS;

EID: 76149118421     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283347be5     Document Type: Review

References (68)

1. Holgate S, Bisgaard H, Bjermer L, et al.. The Brussels Declaration: the need for change in asthma management. Eur Respir J 2008; 32:1433-1442.
2. The Lancet. Still more questions than answers. Lancet 2008; 372: 1009.
3. Sly PD, Boner AL, Björksten B, et al.. Early identification of atopy in the prediction of persistent asthma in children. Lancet 2008; 372:1100-1106.
4. Sears MR, Greene JM, Willan AR, et al.. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349:1414-1422.
5. Horne R, Price D, Cleland J, et al.. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007; 7:8.
6. Haughney J, Price D, Kaplan A, et al.. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008; 102:1681-1693.
7. Boushey HA, Sorkness CA, King TS, et al.., National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005; 352: 1519-1528.
8. Pedersen SE, Bateman ED, Bousquet J, et al.., Gaining Optimal Asthma controL Steering Committee and Investigators. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol 2007; 120:1036-1042.
9. Mendis S, Fukino K, Cameron A, et al.. The availability and affordability of selected essential medicines for chronic diseases in six low- and middleincome countries. Bull World Health Organ 2007; 85:279-288.
10. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008; 372:1107-1119.
11. Turato G, Barbato A, Baraldo S, et al.. Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. Am J Respir Crit Care Med 2008; 178:476-482.
12. Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999; 54:268-272.
13. Woodcock A, Forster L, Matthews E, et al.., Medical Research Council General Practice Research Framework. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med 2003; 349:225-236.
14. Barnes PJ. Is there a role for immunotherapy in the treatment of asthma? No. Am J Respir Crit Care Med 1996; 154:1227-1228.
15. Scadding GK, Durham SR, Mirakian R, et al.. British Society for Allergy and Clinical Immunology. BSACI guidelines for the management of allergic and nonallergic rhinitis. Clin Exp Allergy 2008; 38:19-42.
16. Holgate ST. Novel targets of therapy in asthma. Curr Opin Pulm Med 2009; 15:63-71.
17. Flood-Page P, Swenson C, Faiferman I, et al.., International Mepolizumab Study Group. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med 2007; 176:1062-1071.
18. Rothenberg ME, Klion AD, Roufosse FE, et al.., Mepolizumab HES Study Group. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008; 358:1215-1228.
19. Mehr S, Rego S, Kakakios A, et al.. Treatment of a case of pediatric hypereosinophilic syndrome with antiinterleukin-5. J Pediatr 2009; 155: 289-291.
20. Nair P, Pizzichini MM, Kjarsgaard M, et al.. Mepolizumab for prednisonedependent asthma with sputum eosinophilia. N Engl J Med 2009; 360:985-993.
21. Haldar P, Brightling CE, Hargadon B, et al.. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973-984.
22. Yamane-Ohnuki N, Kinoshita S, Inoue-Urakubo M, et al.. Biotechnol. Bioeng. 2004; 87: 614-622.
23. Austen KF. Biologic implications of the structural and functional characteristics of the chemical mediators of immediate-type hypersensitivity. Harvey Lect 1979; 73:93-161.
24. Holgate ST, Davies DE, Lackie PM, et al.. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000; 105 (2 Pt 1):193-204.
25. Holgate ST. Asthma: more than an inflammatory disease. Curr Opin Allergy Clin Immunol 2002; 2:27-29.
26. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007; 120:1233-1244.
27. Bucchieri F, Puddicombe SM, Lordan JL, et al.. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol 2002; 27:179-185.
28. Wark PA, Johnston SL, Bucchieri F, et al.. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201:937-947.
29. Swindle EJ, Collins JE, Davies DE. Breakdown in epithelial barrier function in patients with asthma: identification of novel therapeutic approaches. J Allergy Clin Immunol 2009; 124:23-34.
30. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2008; 122:689-693.
31. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009; 124:3-20.
32. Tieu DD, Kern RC, Schleimer RP. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124:37-42.
33. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004; 4:978-988.
34. Holgate ST, Davies DE, Powell RM, et al.. Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms. Eur Respir J 2007; 29:793-803.
35. Eder W, Ege MJ, Von Mutius E. The asthma epidemic. N Engl J Med 2006; 355:2226-2235.
36. Nadeem A, Masood A, Siddiqui N. Oxidant-antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options. Ther Adv Respir Dis 2008; 2:215-235.
37. Sears MR. Epidemiology of asthma exacerbations. J Allergy Clin Immunol 2008; 122:662-668.
38. Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics 2002; 109 (2 Suppl):362-367.
39. Simpson A, Maniatis N, Jury F, et al.. Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. Am J Respir Crit Care Med 2005; 172:55-60.
40. Turner SW, Devereux G. Early life influences on the development of allergy and asthma: how early is early? Clin Exp Allergy 2007; 37:163-165.
41. Lucas JS, Inskip HM, Godfrey KM, et al.. Small size at birth and greater postnatal weight gain: relationships to diminished infant lung function. Am J Respir Crit Care Med 2004; 170:534-540.
42. Hå land G, Carlsen KC, Sandvik L, et al.., ORAACLE. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006; 355:1682-1689.
43. Illi S, von Mutius E, Lau S, et al.., Multicentre Allergy Study (MAS) group. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006; 368:763-770.
44. Kurukulaaratchy RJ, Matthews S, Waterhouse L, Arshad SH. Factors influencing symptom expression in children with bronchial hyperresponsiveness at 10 years of age. J Allergy Clin Immunol 2003; 112:311-316.
45. Matricardi PM, Illi S, Grüber C, et al.. Wheezing in childhood: incidence, longitudinal patterns and factors predicting persistence. Eur Respir J 2008; 32:585-592.
46. Wennergren G. What if it is the other way around? Early introduction of peanut and fish seems to be better than avoidance. Acta Paediatr 2009; 98:1085-1087.
47. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood: a prospective study. N Engl J Med 1990; 323:502-507.
48. Haselden BM, Larché M, Meng Q, et al.. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol 2001; 108:394-401.
49. Guilbert TW, Morgan WJ, Zeiger RS, et al.. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354:1985-1997.
50. Murray CS, Woodcock A, Langley SJ, et al.., IFWIN study team. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet 2006; 368:754-762.
51. Jackson DJ, Gangnon RE, Evans MD, et al.. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178:667-672.
52. Raza A, Kurukulaaratchy RJ, Arshad SH. Predicting risk of asthma in wheezing infants. Thorax 2008; 63:842.
53. Arshad SH, Kurukulaaratchy RJ, Fenn M, Matthews S. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest 2005; 127:502-508.
54. Dharmage SC, Erbas B, Jarvis D, et al.. Do childhood respiratory infections continue to influence adult respiratory morbidity? Eur Respir J 2009; 33: 237-244.
55. Wu P, Dupont WD, Griffin MR, et al.. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med 2008; 178:1123-1129.
56. Tschernig T, Debertin AS, Paulsen F, et al.. Dendritic cells in the mucosa of the human trachea are not regularly found in the first year of life. Thorax 2001; 56:427-431.
57. Wan H, Winton HL, Soeller C, et al.. Derp 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999; 104: 123-133.
58. Matzinger P. Friendly and dangerous signals: is the tissue in control? Nat Immunol 2007; 8:11-13.
59. Saglani S, Malmström K, Pelkonen AS, et al.. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005; 171:722-727.
60. Barbato A, Turato G, Baraldo S, et al.. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006; 174:975-981.
61. Saglani S, Payne DN, Zhu J, et al.. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007; 176:858-864.
62. Kim ES, Kim SH, Kim KW, et al.. Basement membrane thickening and clinical features of children with asthma. Allergy 2007; 62:635-640.
63. Bourdin A, Neveu D, Vachier I, et al.. Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol 2007; 119:1367-1374.
64. Law L, Zheng L, Orsida B, et al.. Early changes in basement membrane thickness in airway walls postlung transplantation. J Heart Lung Transplant 2005; 24:1571-1576.
65. Puddicombe SM, Torres-Lozano C, Richter A, et al.. Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. Am J Respir Cell Mol Biol 2003; 28:61-68.
66. Fedorov IA, Wilson SJ, Davies DE, Holgate ST. Epithelial stress and structural remodelling in childhood asthma. Thorax 2005; 60:389-394.
67. Stevens PT, Kicic A, Sutanto EN, et al.. Dysregulated repair in asthmatic paediatric airway epithelial cells: the role of plasminogen activator inhibitor-1. Clin Exp Allergy 2008; 38:1901-1910.
68. Woodruff PG, Modrek B, Choy DF, et al.. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009; 180: 388-395.